Filgrastim biosimilar (PanPharmaceuticals)

非格司亭生物类似药（PanPharmaceuticals）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (PanPharmaceuticals)
Drug Alias Name非格司亭生物仿制药（PanPharmaceuticals）Recombinant human granulocyte macrophage colony stimulating factor (PanPharmaceuticals)rhG-CSF (PanPharmaceuticals)重组人粒细胞刺激因子（PanPharmaceuticals）
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile Neutropenia
Global Approved IndicationsFebrile Neutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHarvest Moon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsFebrile Neutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A